The World Health Organization has validated Timor-Leste's elimination of trachoma as a public-health problem. The decision means the country has met defined disease thresholds and shown that its health system can identify and manage cases that may still occur.
It does not mean the bacterium has vanished everywhere or that eye-care services can stop. Elimination as a public-health problem is a measurable control milestone, while eradication would mean reducing worldwide incidence to zero permanently.
What is trachoma?
Trachoma is an eye disease caused by the bacterium Chlamydia trachomatis. It spreads through contact with eye and nasal discharge from an infected person, including through contaminated hands or materials. Flies can also contribute to transmission in some settings.
Repeated infections can scar the inside of the eyelid. In an advanced condition called trichiasis, eyelashes turn inward and rub against the eye, causing pain, corneal damage and potentially irreversible blindness.
The disease is closely associated with limited access to clean water, sanitation, hygiene and health care. That makes elimination a medical achievement and an infrastructure achievement.
What WHO validation means
WHO reviews evidence submitted by a country and assesses whether infection and trichiasis indicators are below the thresholds that define a public-health problem. Reviewers also examine whether services can detect future cases and provide treatment.
Timor-Leste conducted investigations between 2015 and 2017, including examinations of children on Atauro Island, eye-clinic screening and targeted household searches. WHO says no trachoma was found in those investigations.
Further evidence followed. A 2025 survey analysed 4,949 samples from children aged one to five across all 13 municipalities and found no transmission at a level requiring a trachoma-specific public-health intervention.
Why the regional result matters
Timor-Leste was the last country in WHO's South-East Asia Region where endemic trachoma was still suspected. Its validation therefore means trachoma is no longer considered a public-health problem anywhere in that WHO region.
Countries that never had a history or suspicion of endemic trachoma do not need the same validation process. The regional milestone should not be read as proof that every nation completed an identical elimination campaign.
WHO identifies Timor-Leste as the fourth country in the region and the 33rd worldwide to reach the milestone. Globally, trachoma remains endemic in vulnerable communities, so the wider elimination target has not yet been achieved.
How trachoma is controlled
The standard public-health approach is known as the SAFE strategy:
- Surgery for advanced trichiasis
- Antibiotics to reduce infection
- Facial cleanliness to limit transmission
- Environmental improvement, particularly water and sanitation
Not every district needs every measure at the same intensity. Surveys help programmes determine where mass treatment is required and where routine eye-care and surveillance are sufficient.
Why work continues after validation
Timor-Leste must preserve the ability to identify and manage individual cases of trichiasis and other eye diseases. WHO says specialised services remain available through the National Eye Centre at Hospital Nacional Guido Valadares in Dili and through outreach to municipalities.
Surveillance will be integrated with other neglected-tropical-disease systems. This can make limited health resources more efficient, but only if staff, referral routes and data quality remain strong.
Water, sanitation and hygiene programmes also remain essential. Disease indicators can stay below public-health thresholds only when the conditions that enabled transmission continue to improve.
What readers should take from the milestone
The result shows that a small country can assemble convincing national evidence and maintain services after transmission falls. It also demonstrates why public-health headlines require precise language: “eliminated as a public-health problem” is meaningful, but it is not the same as “disease no longer exists.”
WHO's official validation announcement explains the surveys and criteria. Our report on Bhutan's rabies milestone covers another recent disease-elimination achievement, while the DRC Ebola explainer shows how outbreak response differs from elimination work. More global coverage is available in the News section.
